What is the share price of Raaj Medisafe India Ltd (RAAJMEDI) today?
The share price of RAAJMEDI as on 15th September 2026 is ₹100.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Raaj Medisafe India Ltd (RAAJMEDI) share?
The past returns of Raaj Medisafe India Ltd (RAAJMEDI) share are- Past 1 week: 0.12%
- Past 1 month: 37.10%
- Past 3 months: 33.45%
- Past 6 months: 38.22%
- Past 1 year: 33.47%
- Past 3 years: 159.93%
- Past 5 years: 177.29%
What are the peers or stocks similar to Raaj Medisafe India Ltd (RAAJMEDI)?
The peers or stocks similar to Raaj Medisafe India Ltd (RAAJMEDI) include:What is the market cap of Raaj Medisafe India Ltd (RAAJMEDI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Raaj Medisafe India Ltd (RAAJMEDI) is ₹164.00 Cr as of 15th September 2026.What is the 52 week high and low of Raaj Medisafe India Ltd (RAAJMEDI) share?
The 52-week high of Raaj Medisafe India Ltd (RAAJMEDI) is ₹104.45 and the 52-week low is ₹64.08.What is the PE and PB ratio of Raaj Medisafe India Ltd (RAAJMEDI) stock?
The P/E (price-to-earnings) ratio of Raaj Medisafe India Ltd (RAAJMEDI) is 91.11. The P/B (price-to-book) ratio is 3.51.Which sector does Raaj Medisafe India Ltd (RAAJMEDI) belong to?
Raaj Medisafe India Ltd (RAAJMEDI) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Raaj Medisafe India Ltd (RAAJMEDI) shares?
You can directly buy Raaj Medisafe India Ltd (RAAJMEDI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Raaj Medisafe India Ltd
RAAJMEDI Share Price
BSE₹100.100.25% (+0.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
RAAJMEDI Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
RAAJMEDI Performance & Key Metrics
RAAJMEDI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 69.20 | 3.51 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.99 | 5.89 | 0.48% |
RAAJMEDI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
RAAJMEDI Company Profile
Raaj Medisafe is engaged in manufacturing of disposable hygiene products.
PE Ratio
40.47
40.47
1Y Return
13.17%
13.17%
Buy Reco %
77.78
77.78
POLYMED
PE Ratio
54.70
54.70
1Y Return
14.05%
14.05%
Buy Reco %
80.00
80.00
PE Ratio
99.48
99.48
1Y Return
31.90%
31.90%
TARSONS
PE Ratio
115.71
115.71
1Y Return
2.28%
2.28%
Buy Reco %
100.00
100.00
LAXMIDENTL
PE Ratio
38.53
38.53
1Y Return
35.23%
35.23%
Buy Reco %
100.00
100.00
RAAJMEDI Forecast
RAAJMEDI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
RAAJMEDI
RAAJMEDI
Income
Balance Sheet
Cash Flow
Quarterly Normal View
RAAJMEDI Income Statement
RAAJMEDI Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.40 | 10.91 | 10.91 | 14.58 | 24.51 | 15.83 | 18.64 | 20.75 | 25.36 | 29.61 | ||||||||||
Operating & Other expenses | 9.04 | 9.17 | 9.17 | 12.38 | 21.29 | 13.20 | 15.66 | 17.02 | 22.37 | 25.40 | ||||||||||
EBITDA | 2.36 | 1.74 | 1.74 | 2.20 | 3.22 | 2.63 | 2.98 | 3.73 | 2.99 | 4.21 | ||||||||||
| Depreciation/Amortization | 0.23 | 0.23 | 0.23 | 0.40 | 0.44 | 0.49 | 0.43 | 0.50 | 0.63 | 0.71 | ||||||||||
| PBIT | 2.13 | 1.51 | 1.51 | 1.80 | 2.78 | 2.14 | 2.55 | 3.23 | 2.36 | 3.50 | ||||||||||
| Interest & Other Items | 0.47 | 0.36 | 0.36 | 0.52 | 0.68 | 0.68 | 0.82 | 1.38 | 1.08 | 0.86 | ||||||||||
| PBT | 1.66 | 1.15 | 1.15 | 1.28 | 2.10 | 1.46 | 1.73 | 1.85 | 1.28 | 2.64 | ||||||||||
| Taxes & Other Items | 0.96 | 0.18 | 0.18 | 0.25 | -1.37 | 0.00 | 0.00 | -0.05 | 4.52 | 0.66 | ||||||||||
| Net Income | 0.70 | 0.97 | 0.97 | 1.03 | 3.47 | 1.46 | 1.73 | 1.90 | -3.24 | 1.98 | ||||||||||
| EPS | 0.66 | 0.74 | 0.74 | 0.76 | 2.61 | 1.11 | 1.32 | 1.44 | -1.96 | 1.20 |
RAAJMEDI Company Updates
RAAJMEDI Stock Peers
RAAJMEDI Past Performance & Peer Comparison
RAAJMEDI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Raaj Medisafe India Ltd | 91.11 | 3.51 | — |
| Inventurus Knowledge Solutions Ltd | 40.47 | 10.43 | — |
| Poly Medicure Limited | 54.70 | 5.60 | 0.20% |
| Molbio Diagnostics Limited | 99.48 | 12.66 | — |
RAAJMEDI Stock Price Comparison
Compare RAAJMEDI with any stock or ETFCompare RAAJMEDI with any stock or ETF
RAAJMEDI
RAAJMEDI Holdings
RAAJMEDI Shareholdings
RAAJMEDI Promoter Holdings Trend
RAAJMEDI Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 14.71%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
RAAJMEDI Institutional Holdings Trend
RAAJMEDI Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 3.12%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
RAAJMEDI Shareholding Pattern
RAAJMEDI Shareholding Pattern
RAAJMEDI Shareholding History
RAAJMEDI Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing RAAJMEDI stock
smallcases containing RAAJMEDI stock
Looks like this stock is not in any smallcase yet.
RAAJMEDI Events
RAAJMEDI Events
RAAJMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RAAJMEDI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
RAAJMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RAAJMEDI has not given any dividends in last 5 years
RAAJMEDI Dividends
RAAJMEDI Dividends
Hmm, looks like data is unavailable here. Please come back after some timeRAAJMEDI Stock News & Opinions
RAAJMEDI Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Raaj Medisafe secures Rs 17.02 crore order from Madhya Pradesh Public Health Services CorporationRaaj Medisafe (India) Limited announced it has received a Letter of Award from Madhya Pradesh Public Health Services Corporation Limited for the supply of 29,88,220 Baby Diapers (Small), valued at approximately Rs 17.02 Crores inclusive of GST, to be distributed to government hospitals across Madhya Pradesh. The order, awarded on August 31, 2026, requires supply within 18 months and does not involve any related party transactions, according to a regulatory filing.
2 weeks agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India Limited reports no deviations in fund utilization for acquisitions and expansionRaaj Medisafe India Limited informed the BSE that it has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue of Rs 18,01,25,000 on March 26, 2026, for the quarter ended June 30, 2026, noting there were no deviations or variations in the use of funds, which were originally intended for the acquisition of Fabrizo Industries Private Limited’s Goa-based manufacturing unit, expansion plans, working capital, and general corporate purposes.
1 month agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India Limited names Vipul Parakh as CFO, effective August 2026Raaj Medisafe India Limited announced that its Board of Directors appointed Mr. Vipul Parakh as Chief Financial Officer, effective August 12, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
1 month agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India Limited to appoint CFO and review financial results at meetingRaaj Medisafe India Limited will hold a board meeting on August 12, 2026, to consider the appointment of a Chief Financial Officer and to take on record the unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from the statutory auditor. The board will also review reports submitted to the BSE Ltd. in accordance with SEBI (LODR), 2015, including a statement of variation of utilization of funds raised on March 26, 2026, through a preferential allotment of equity shares.
1 month agoCapital Market - Live
Earnings
Earnings
Raaj Medisafe India reports standalone net loss of Rs 3.23 crore in the March 2026 quarterNet loss of Raaj Medisafe India reported to Rs 3.23 crore in the quarter ended March 2026 as against net profit of Rs 3.48 crore during the previous quarter ended March 2025. Sales rose 2.79% to Rs 25.08 crore in the quarter ended March 2026 as against Rs 24.40 crore during the previous quarter ended March 2025. For the full year,net profit declined 70.47% to Rs 1.81 crore in the year ended March 2026 as against Rs 6.13 crore during the previous year ended March 2025. Sales rose 28.18% to Rs 80.01 crore in the year ended March 2026 as against Rs 62.42 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales25.0824.40 3 80.0162.42 28 OPM %10.8512.79 -14.7113.84 - PBDT1.922.55 -25 8.376.71 25 PBT1.292.11 -39 6.335.26 20 NP-3.233.48 PL 1.816.13 -70 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India schedules board meetingRaaj Medisafe India will hold a meeting of the Board of Directors of the Company on 29 May 2026.
3 months agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India to conduct board meetingRaaj Medisafe India will hold a meeting of the Board of Directors of the Company on 26 March 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Raaj Medisafe India standalone net profit rises 83.50% in the December 2025 quarterNet profit of Raaj Medisafe India rose 83.50% to Rs 1.89 crore in the quarter ended December 2025 as against Rs 1.03 crore during the previous quarter ended December 2024. Sales rose 41.95% to Rs 20.71 crore in the quarter ended December 2025 as against Rs 14.59 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales20.7114.59 42 OPM %17.7715.15 - PBDT2.341.68 39 PBT1.841.28 44 NP1.891.03 83 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India to announce Quarterly ResultRaaj Medisafe India will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Raaj Medisafe India to hold EGMRaaj Medisafe India announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.41%, vs industry avg of 18.08%
Over the last 5 years, market share decreased from 0.77% to 0.72%
Over the last 5 years, net income has grown at a yearly rate of -4.87%, vs industry avg of 6.95%